EP2519219A2 - Produit de traitement des cheveux comprenant des composés substitués par des trialcoxysilanes et des macromolécules modifiées par des alcoxysilyles - Google Patents

Produit de traitement des cheveux comprenant des composés substitués par des trialcoxysilanes et des macromolécules modifiées par des alcoxysilyles

Info

Publication number
EP2519219A2
EP2519219A2 EP10785091A EP10785091A EP2519219A2 EP 2519219 A2 EP2519219 A2 EP 2519219A2 EP 10785091 A EP10785091 A EP 10785091A EP 10785091 A EP10785091 A EP 10785091A EP 2519219 A2 EP2519219 A2 EP 2519219A2
Authority
EP
European Patent Office
Prior art keywords
group
weight
ethyl
formula
independently
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP10785091A
Other languages
German (de)
English (en)
Inventor
Matthias Schweinsberg
Winfried Emmerling
Lars Zander
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henkel AG and Co KGaA
Original Assignee
Henkel AG and Co KGaA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel AG and Co KGaA filed Critical Henkel AG and Co KGaA
Publication of EP2519219A2 publication Critical patent/EP2519219A2/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/04—Preparations for permanent waving or straightening the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
    • A61K8/585—Organosilicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86—Polyethers

Definitions

  • the present invention relates to hair treatment compositions containing at least one trialkoxysilane-substituted compound and at least one alkoxysilyl-modified macromolecule, the use of these agents for the temporary deformation and / or care of keratin-containing fibers and a corresponding method of application.
  • the permanent hair deformation is carried out according to the known perm process in such a way that the hair is mechanically deformed and the deformation z. B. by winding on hair curlers or Papilloten sets or defined using a curling iron.
  • the hair is treated with the aqueous preparation of a keratin-reducing substance and rinsed after a contact time with water or an aqueous solution. Sometimes it proves to be advantageous to support the transformation by using a heat hood as a heat source.
  • the hair is then treated with the aqueous preparation of an oxidizing agent. After a period of action, this is also rinsed out of the hair and the hair from the mechanical deformation aids (winder, papillots) freed.
  • the permanent smoothing of keratin-containing fibers is achieved analogously by the use of keratin-reducing and -oxidierenden compositions.
  • the frizzy hair is either wound on large diameter winders, usually more than 15 mm, or the hair is combed smooth under the action of the keratin reducing composition.
  • the fiber is also possible to put the fiber on Smoothing out the smoothing board.
  • Smoothing boards are usually rectangular boards, for example made of plastic.
  • the fiber is wetted with the keratin-reducing preparation.
  • styling agents In addition to a high degree of hold, styling agents must meet a whole range of other requirements. These may be broad in properties on the hair, properties of the particular formulation, e.g. Properties of the foam, the gel or the sprayed aerosol, and properties that affect the handling of the styling agent, are subdivided, with the properties of the hair is of particular importance. Particularly noteworthy are moisture resistance, low tackiness and a balanced conditioning effect. Furthermore, a styling agent should be universally applicable as possible for all hair types.
  • the polymers can be subdivided into cationic, anionic, nonionic and amphoteric film-forming and / or setting polymers.
  • the polymers yield a polymer film even when used on a small amount on the hair, which on the one hand gives the hairstyle a strong hold, but on the other hand is sufficiently flexible so as not to break under stress. If the polymer film is too brittle, it results in the formation of so-called Filmpiaken, that is residues that detach during the movement of the hair and give the impression that the user of the corresponding styling agent would dandruff.
  • a first subject of the present invention is therefore an agent for treating keratin-containing fibers, especially human hair, contained in a cosmetically acceptable carrier
  • R 1 is a (C 1 to C 4 ) -alkyl group
  • K ' represents a connectivity selected from a covalent bond or from a molecular fragment having two free valences
  • R 2 is a structural fragment comprising at least one substituent selected from quaternary ammonium group, tertiary amino group, secondary amino group, primary amino group, anionic group.
  • all animal hair e.g. Wool, horsehair, angora hair, furs, feathers and products or textiles made from them.
  • the keratinic fibers are human hairs.
  • a "macromolecule” within the meaning of the invention is a molecule having a molecular weight of at least 3000 g / mol, including polymers and dendrimers.
  • the alkoxysilyl-functionalized macromolecules are preferably present in the compositions according to the invention in an amount of from 0.01 to 29.99% by weight, particularly preferably from 0.1 to 14.9% by weight, very particularly preferably from 0.1 to 9.5 Wt .-%, most preferably from 0.2 to 3.0 wt .-%, each based on the weight of the total composition.
  • Preferred marcomolecules are based on polymers (such as, for example, polysaccharides, (eg cellulose or starch) or on polymers starting from ethylenically unsaturated monomers, such as, for example, acrylic acid, methacrylic acid, 2-hydroxyethylacrylic acid, 2-hydroxyethylmethacrylic acid, acrylamide, methacrylamide, 2-hydroxyethylacrylamide, 2- Hydroxyethylmethacrylamid) where these polymers having at least one alkoxysilyl group of the formula (RO) n R '(3- n) Si- * , wherein R and R' independently of a (Ci to C 4 ) alkyl group (in particular methyl or Ethyl), x is 1, 2 or 3, are functionalized.
  • Preferred polymers comprise at least one structural unit of the formula (T-2),
  • R is a hydrogen atom or a methyl group
  • n 2 or 3
  • R ' is methyl or ethyl
  • X is an oxygen atom or a group NH.
  • alkoxysilyl-functionalized macromolecule is selected from alkoxysilyl-functionalized, polyether-modified compounds.
  • those alkoxysilyl-functionalized polyether-modified, organic compounds are preferably selected which have at least three polyether substituents, where the polyethers comprise a polyoxyalkylene chain of ethylene oxide units or of ethylene oxide and propylene oxide units, with a maximum proportion of 50% by weight. to propylene oxide units, based on the weight of the polyoxyalkylene chain.
  • polyether substituent is meant a chemical structure fragment comprising a polyoxyalkylene chain of ethylene oxide units or of ethylene oxide and propylene oxide units containing a maximum of 50% by weight of propylene oxide units based on the weight of the polyoxyalkylene chain the structural fragment mediating directly or via a chemical bond is covalently bonded to an organic compound.
  • an ethylene oxide unit is a unit of the general formula (1)
  • a unit of the general formula (2) is understood to mean a propylene oxide unit.
  • organic compounds chemical compounds based on a hydrocarbon structural fragment
  • Hydrocarbon structural fragments are derived from linear, branched, cyclic or heterocyclic hydrocarbons, all of which may be saturated, unsaturated or aromatic.
  • polyether-modified organic compounds are understood as meaning organic compounds which are modified with polyether-containing substituents, the polyether substituents in each case forming a chemical bond to the organic compound to be modified.
  • the maximum proportion of propylene oxide units is preferably 40% by weight and more preferably not more than 30% by weight, based on the weight of A.
  • Said alkoxysilyl-functionalized, polyether-modified, organic compounds which have at least three polyether substituents are preferably selected from at least one compound of the general formula (PE-1) wherein
  • A is a polyoxyalkylene chain of ethylene oxide units or of ethylene oxide and
  • Propylene oxide units means, with a maximum proportion of 50 wt .-% of
  • K and K 'independently represent a connectivity selected from a covalent one
  • T is a radical -Si (OR) x (R ') 3 . x ,
  • R and R ' independently of one another, are a (C 1 to C 4 ) -alkyl group (especially methyl or ethyl), x is 1, 2 or 3,
  • Q is an organic structural fragment derived from linear, branched, cyclic or heterocyclic hydrocarbons, all of which may be saturated, unsaturated or aromatic,
  • n stands for an integer from 3 to 64 (in particular for 3, 4, 5, 6, 7 or 8).
  • a in accordance with formula (PE-1) is preferably a structural fragment of the formula (A1) OCH 2 CH 2 ) p - (OCH 2 CH (CH 3 )) m - * (A1) wherein
  • p is an integer from 1 to 500
  • n is an integer from 0 to 500 and
  • the structural fragment of the formula (A1) has a maximum proportion of 50% by weight of propylene oxide units, based on the weight of the structural fragment (A1).
  • the ethylene oxide and propylene oxide units of the formula (PE-1) or of the formula (A1) may be randomly distributed or distributed in a gradient or present in at least two blocks.
  • the maximum proportion of propylene oxide units is preferably 40 wt .-% and especially preferably at most 30% by weight, based on the weight of A.
  • radicals K or K 'according to formula (PE-1) are preferably independently of one another a covalent bond, an oxy group, a (Ci to Ce) alkylene group, an imino group or at least one of the following connectivities (K1) to (K10)
  • R and R independently of one another represent methylene, ethane-1, 2-diyl, propane-1,2-diyl, propane
  • R ' represents a hydrogen atom or a (C 1 to C 4 ) -alkyl group
  • R '"independently of one another denotes a (C 1 to C 4 ) -alkyl group or an aryl group.
  • T is preferably a radical -Si (OR) x (R ') 3 according to formula (PE-1).
  • x wherein R and R 'independently of one another are a (C 1 to C 4 ) -alkyl group (especially methyl or ethyl) and x is 2 or 3 (preferably triethoxysilyl).
  • R and R 'independently of one another are a (C 1 to C 4 ) -alkyl group (especially methyl or ethyl) and x is 2 or 3 (preferably triethoxysilyl).
  • Very particular preference is given to the structural fragment -KT according to formula (PE-1) or the following formulas (PE-1 a) to (PE-1f) for a group
  • Q is according to formula (PE-1) preferably a corresponding organic radical having 2 to 30 carbon atoms, more preferably having 2 to 20 carbon atoms.
  • Q is preferably derived from glycerin, monosaccharide, disaccharide. Most preferably, Q is derived from a compound selected from sorbitol, 1,5-anhydro-sorbitol, 1,4-anhydrosorbitol, inositol, xylitol, mannitol, gluconolactone, glucuronic acid, 1, 2,6-hexanetriol, hydroxyethylsorbitol, phytantriol , Hydroxypropyl phytantriol, lactitol, maltitol, pentaerythritol, polyglycerol-3, glucose, fructose, galactose, ribose, xylose, mannose, sucrose, cellobiose, gentiobiose, isomaltose, lactose, lactulose, maltose, maltutose, melibiose, trehalose, nigerose
  • Very particularly preferred alkoxysilyl-functionalized, polyether-modified organic compounds are selected from at least one compound of the formula (PE-1a) or (PE-1 b) or (PE-1c) or (PE-1d) or (PE-1 e ) or (PE-1f) or mixtures thereof,
  • At least three groups R represent a group - (CH 2 CH 2 O) p - (CHCH 3 CH 2 O) m -KT and the remaining groups R stand for a hydrogen atom or a group -KT, in which independently of one another
  • p is an integer from 1 to 500 and m is an integer from 0 to 500 and p and m have a relationship to each other that a maximum proportion of 50 wt .-% (preferably at most 40 wt .-%, particularly preferably maximum 30% by weight) of propylene oxide units, based on the weight of the corresponding polyoxyalkylene chain, K stands for a connectivity selected from a covalent bond or from a
  • T is a radical * -Si (OR) x (R ') 3 . x , wherein R and R 'independently represent a (C 1 to C 4 ) alkyl group (especially methyl or ethyl), x is 1, 2 or 3;
  • At least three groups R represent a group - (CH 2 CH 2 O) p - (CHCH 3 CH 2 O) m -KT and the remaining groups R stand for a hydrogen atom or a group -KT, in which independently of one another
  • p is an integer from 1 to 500 and m is an integer from 0 to 500 and p and m have a relationship to each other that a maximum proportion of 50 wt .-% (preferably at most 40 wt .-%, particularly preferably maximum 30% by weight) of propylene oxide units, based on the weight of the corresponding polyoxyalkylene chain, K stands for a connectivity selected from a covalent bond or from a
  • T is a radical -Si (OR) x (R ') 3 . x ,
  • R and R 'independently of one another represent a (C 1 to C 4 ) -alkyl group (especially methyl or ethyl), x is 1, 2 or 3;
  • At least three groups R represent a group - (CH 2 CH 2 O) p - (CHCH 3 CH 2 O) m -KT and the remaining groups R stand for a hydrogen atom or a group -KT, in which independently of one another
  • p is an integer from 1 to 500 and m is an integer from 0 to 500 and p and m have a relationship to each other that a maximum proportion of 50 wt .-% (preferably at most 40 wt .-%, particularly preferably maximum 30% by weight) of propylene oxide units, based on the weight of the corresponding polyoxyalkylene chain, K stands for a connectivity selected from a covalent bond or from a
  • T is a radical -Si (OR) x (R ') 3 . x , wherein R and R 'independently represent a (C 1 to C 4 ) alkyl group (especially methyl or ethyl), x is 1, 2 or 3;
  • At least three groups R represent a group - (CH 2 CH 2 O) p - (CHCH 3 CH 2 O) m -KT and the remaining groups R stand for a hydrogen atom or a group -KT, in which independently of one another
  • p is an integer from 1 to 500 and m is an integer from 0 to 500 and p and m have a relationship to each other that a maximum proportion of 50 wt .-% (preferably at most 40 wt .-%, particularly preferably maximum 30% by weight) of propylene oxide units, based on the weight of the corresponding polyoxyalkylene chain, K stands for a connectivity selected from a covalent bond or from a
  • T is a radical -Si (OR) x (R ') 3-x ,
  • R and R 'independently of one another represent a (C 1 to C 4 ) -alkyl group (especially methyl or ethyl), x is 1, 2 or 3;
  • p is an integer from 1 to 500 and m is an integer from 0 to 500 and p and m have a relationship to each other that a maximum proportion of 50 wt .-% (preferably at most 40 wt .-%, particularly preferably maximum 30% by weight) of propylene oxide units, based on the weight of the corresponding polyoxyalkylene chain;
  • K independently represent a connectivity selected from a covalent one
  • T is a radical -Si (OR) x (R ') 3 . x ,
  • Methyl or ethyl x is 1, 2 or 3.
  • the ethylene oxide and propylene oxide units may be randomly distributed or distributed in a gradient or in at least two blocks.
  • compositions according to the invention necessarily contain at least one trialkoxysilane of the above formula (T-1).
  • T-1 trialkoxysilanes are different from the macromolecules of feature (a). They therefore have a molecular weight of less than 3000 g / mol, in particular less than 1000 g / mol.
  • Trialkoxysilanes of the above formula (T-1) are in the agent according to the invention preferably in an amount of 0.01 to 29.99 wt .-%, particularly preferably from 0, 1 to 14.9 wt .-%, most preferably 0 , 1 to 9.5 wt .-%, most preferably from 0.2 to 3.0 wt .-%, each based on the weight of the total composition.
  • Preferred trialkoxysilane compounds of the above formula (T-1) are those in which R 1 of the formula (T-1) is methyl or ethyl, particularly preferably ethyl.
  • the connectivity K 'according to formula (T-1) is preferably (C 2 to Ce) -alkylene (in particular
  • Ethane-1, 2-diyl or propane-1,3-diyl or for one of the formulas (K1 1), (K12) or (K13)
  • R is methylene, ethane-1, 2-diyl, propane-1, 2-diyl, propane-1, 3-diyl, butane-1, 2-diyl, butane-1, 3-diyl, butane-1, 4 -diyl or phenylene (especially ethane-1, 2-diyl or propane-1, 3-diyl), R 'is a hydrogen atom or a (Ci to C 4 ) alkyl group.
  • the compounds of the feature (ii) may be selected from those bearing anionic groups in the radical R 2 .
  • the anionic groups are preferably a molecule fragment which comprises 1 to 5, preferably 3, 4 or 5, deprotonatable acid groups.
  • the anionic groups or the deprotonatable acid groups of said molecular fragments are preferably selected from carboxyl group and / or sulfonic acid group and / or phosphate or their respective salt forms (in particular Carboxyl group and / or sulfonic acid group or their respective salt forms, particularly preferably carboxyl group or its salt form).
  • the group R 2 of the formula (T-1) contains at least one, preferably at least two, particularly preferably 1 to 5, especially 2 to 5, in particular 2, 3, 4 or 5 carboxymethyl units.
  • said molecule fragment is an ethylenediaminetriacetate moiety covalently bonded via one of its nitrogen atoms to the connectivity K 'of formula (T-1).
  • radical R 2 may comprise a tertiary amino group, secondary amino group or primary amino group.
  • the groups 3-aminopropyl, 2-aminoethyl, aminomethyl, N, N-3-dimethylaminopropyl, N, N-2-dimethylaminoethyl, ⁇ , ⁇ -dimethylaminomethyl, N, N-3-diethylaminopropyl, N, N-2-diethylaminoethyl or ⁇ , ⁇ -Diethylaminomethyl are preferably suitable structural fragments * -K'-R 2 of the formula (T-1).
  • the trialkoxysilyl compounds of the formula (T-1) are selected from those which carry at least one quaternary ammonium radical in the radical R 2 .
  • the groups N, N, N-3-trimethylammoniopropyl, N, N, N-2-trimethylammonioethyl, ⁇ , ⁇ , ⁇ -trimethylammoniomethyl, N, N, N-3-triethylammoniopropyl, N, N, N-2-triethylammonioethyl or ⁇ , ⁇ , ⁇ -triethylammoniomethyl are preferably suitable structural fragments * -K'-R 2 of the formula (T-1).
  • radical R 2 of the formula (T-1) is a group of
  • K represents a direct bond or a (C 2 to C 6 ) -alkylene group (in particular
  • R 3 is methyl, ethyl or benzyl
  • R 4 and R 5 independently represent a methyl group, an ethyl group, a (C 8 to C22) alkyl group, a (Cs to C22) alkenyl group, a 2 - ((C 8 to C22) - alkylcarbonyloxy) ethyl group, a 2 - ((C 8 to C 22) alkenylcarbonyloxy) ethyl group.
  • R 2 are derived from cationic surfactants.
  • the structural fragments of the formula (T-3) are preferred in which at least one of the groups R 4 or R 5 is a (C 8 to C 2 2) -alkyl group, a (C 8 to C 2 2) -alkenyl group, is a 2 - ((C 8 to C 2 2) alkylcarbonyloxy) ethyl group or a 2 - ((C 8 to C 2 2) alkenylcarbonyloxy) ethyl group.
  • said trialkoxysilane compounds are selected from the following compounds of the formula (T-1a) (T-1a)
  • R 3 is methyl, ethyl or benzyl
  • R 4 and R 5 independently represent a methyl group, an ethyl group, a (C 8 to C22) alkyl group, a (C 8 to C22) alkenyl group, a 2 - ((C 8 to C22) - alkylcarbonyloxy) ethyl group, a 2 - ((C 8 to C 22) alkenylcarbonyloxy) ethyl group, a (C 8 to C 22) alkylamido (C 2 to C 3) alkyl group.
  • trialkoxysilane compound is in turn preferably selected from the formulas (T)
  • R is a (C 8 to C 2 2) acyl group and R 3 is methyl, ethyl or benzyl (especially methyl);
  • R is a (C 8 to C 22) alkyl group
  • each R is a (C 8 to C 2 2) alkyl group
  • R is a (C 8 to C 2 2) alkyl group.
  • Such compounds are prepared by reacting 3-triethoxysilylpropane isocyanate with a hydroxy-containing cationic surfactant (eg N- (2-hydroxyethyl) -N-methyl-N, N-bis (2-hexadecanoyloxyethyl) ammonium methosulfate (Dehyquart AU from Cognis)) in 1, 4-dioxane as a solvent or without the use of solvents.
  • a hydroxy-containing cationic surfactant eg N- (2-hydroxyethyl) -N-methyl-N, N-bis (2-hexadecanoyloxyethyl) ammonium methosulfate (Dehyquart AU from Cognis)
  • the agents according to the invention additionally contain as activator at least one further compound selected from organic amines comprising 2 to 20 carbon atoms, carboxylate complex compounds of tin, alkoxide compounds of tin, carboxylate complex compounds of lead, organoaluminum compounds, metal complexes of organic dicarbonyl compounds, metal complexes of organic dicarboxylic acid esters.
  • activators are different from the alkoxysilanes of the formula (T-1) and the alkoxysilane-modified macromolecular compounds.
  • Preferred activators are selected from organic amines comprising 2 to 20 carbon atoms.
  • cyclic (in particular bicyclic) organic amines having at least 2 to 20 carbon atoms are preferred.
  • the organic amines are preferably selected from at least one compound from the group consisting of 1, 4-diazabicyclo [2.2.2] octane (also referred to as DABCO), 1, 8-diazabicyclo [5,4,0] undec-7-ene (also DBU), 1, 5-diazabicyclo [4,3,0] non-5-ene (also referred to as DBN), n-butylamine, n-octylamine, laurylamine, di-n-butylamine, 2-aminoethanesulfonic acid, N , N-2-dimethylaminoethanesulfonic acid, 2-aminoethanol, di (2-hydroxyethyl) amine, tri (2-hydroxyethyl) amine, diethylenetriamine, triethylenetetramine, oleylamine, cyclohexylamine, benzylamine, ⁇ , ⁇ -diethylaminopropylamine, xylylenediamine
  • DABCO Diazabicyclo [2.2.2] octane
  • DBN 1, 5-diazabicyclo [4,3,0] non-5-ene
  • DBU 1,8-diazabicyclo [5,4,0] undec-7-en
  • Preferred carboxylate complex compounds of tin are selected from dibutyltin dilaurate (DBTL), dibutyltin diacetate, dibutyltin diethylhexanoate, dibutyltin dioctoate, dibutyltin dimethylmaleate, dibutyltin diethyl maleate, dibutyltin dibutyl maleate,
  • DBTL dibutyltin dilaurate
  • dibutyltin diacetate dibutyltin diethylhexanoate
  • dibutyltin dioctoate dibutyltin dimethylmaleate
  • dibutyltin diethyl maleate dibutyltin dibutyl maleate
  • Preferred alkoxide compounds of tin are selected from dibutyltin dimethoxide, dibutyltin diphenoxide, and dibutyltin diisoproxide.
  • Preferred metal complexes of organic dicarbonyl compounds or metal complexes of organic dicarboxylic acid esters are selected from aluminum trisacetylacetonate, aluminum trisethylacetoacetate, diisopropoxyaluminum ethylacetoacetate; Zirconium tetraacetylacetonate, and titanium tetraacetylacetonate.
  • the agent according to the invention preferably contains the activators in an amount of from 0.0001 to 10.0% by weight, particularly preferably from 0.01 to 5.0% by weight, based in each case on the weight of the entire ready-to-use agent.
  • compositions according to the invention contain the ingredients or active substances in a cosmetically acceptable carrier.
  • Preferred cosmetically acceptable carriers are aqueous, alcoholic or aqueous-alcoholic media with preferably at least 10% by weight of water, based on the total agent.
  • alcohols it is possible in particular to include the lower alcohols having 1 to 4 carbon atoms usually used for cosmetic purposes, such as, for example, ethanol and isopropanol.
  • the agent therefore additionally contains at least one alcohol which has 2 to 6 carbon atoms and 1 to 3 hydroxyl groups.
  • This additional alcohol is again preferably selected from at least one compound of the group formed from ethanol, ethylene glycol, isopropanol, 1,2-propylene glycol, 1,3-propylene glycol, glycerol, n-butanol, 1,3-butylene glycol.
  • a most preferred alcohol is ethanol.
  • the additional alcohol having 2 to 6 carbon atoms and 1 to 3 hydroxyl groups is preferably in the composition of the present invention in an amount of 20% by weight to 65% by weight, especially 25% by weight to 50% by weight, respectively based on the weight of the cosmetic product.
  • organic solvents or a mixture of solvents having a boiling point below 400 ° C in an amount of 0, 1 to 15 weight percent, preferably from 1 to 10 weight percent based on the total agent may be included.
  • Particularly suitable as additional co-solvents are unbranched or branched hydrocarbons such as pentane, hexane, isopentane and cyclic hydrocarbons such as cyclopentane and cyclohexane.
  • particularly preferred water-soluble solvents is polyethylene glycol in an amount of up to 30 wt .-% based on the total agent.
  • compositions according to the invention preferably contain from 0.01 to 30% by weight of polyethylene glycol and / or polypropylene glycol, based on the total agent.
  • the agents according to the invention preferably additionally comprise at least one surfactant, nonionic, anionic, cationic and ampholytic surfactants being suitable in principle.
  • the group of ampholytic or amphoteric surfactants includes zwitterionic surfactants and ampholytes.
  • the surfactants according to the invention may already have emulsifying activity. The use of at least one nonionic surfactant and / or at least one cationic surfactant is preferred in this embodiment of the invention.
  • the additional surfactants are in the inventive composition preferably in an amount of 0.01 wt .-% to 5 wt .-%, particularly preferably from 0.05 wt .-% to 0.5 wt .-%, each based on the Weight of the agent, included.
  • agents according to the invention additionally comprise at least one nonionic surfactant.
  • Nonionic surfactants contain as hydrophilic group e.g. a polyol group, a polyalkylene glycol ether group, or a combination of polyol and polyglycol ether groups.
  • hydrophilic group e.g. a polyol group, a polyalkylene glycol ether group, or a combination of polyol and polyglycol ether groups.
  • Such compounds are, for example
  • Ci2-C3o fatty acid mono- and diesters of addition products of 1 to 30 moles of ethylene oxide with glycerol,
  • Polyol fatty acid esters such as the commercial product Hydagen ® HSP (Cognis) or
  • R 1 CO is a linear or branched, saturated and / or unsaturated acyl radical having 6 to 22 carbon atoms
  • R 2 is hydrogen or methyl
  • R 3 is a linear or branched alkyl radical having 1 to 4 carbon atoms and w is a number from 1 to 20 stands,
  • Hydroxy mixed ethers as described, for example, in DE-OS 19738866, sorbitan fatty acid esters and addition products of ethylene oxide onto sorbitan fatty acid esters, for example the polysorbates,
  • R 4 is an alkyl or alkenyl radical having 4 to 22 carbon atoms
  • G is a sugar radical having 5 or 6 carbon atoms
  • p is a number from 1 to 10. They can be obtained by the relevant methods of preparative organic chemistry.
  • the alkyl and alkenyl oligoglycosides can be derived from aldoses or ketoses with 5 or 6 carbon atoms, preferably glucose.
  • the preferred alkyl and / or alkenyl oligoglycosides are thus alkyl and / or alkenyl oligoglucosides.
  • alkyl and / or alkenyl used oligoglycosides having a mean degree of oligomerization p of 1, 1 to 3.0.
  • alkyl and / or alkenyl oligoglycosides whose degree of oligomerization is less than 1.7 and in particular between 1.2 and 1.4 are preferred.
  • the alkyl or alkenyl radical R 4 can be derived from primary alcohols having 4 to 1 1, preferably 8 to 10 carbon atoms. Typical examples are butanol, caproic alcohol, caprylic alcohol, capric alcohol and undecyl alcohol, and technical mixtures thereof, as are obtained, for example, in the hydrogenation of technical fatty acid methyl esters or in the hydrogenation of aldehydes from Roelen's oxosynthesis.
  • the alkyl or alkenyl radical R 15 can also be derived from primary alcohols having 12 to 22, preferably 12 to 14 carbon atoms.
  • Typical examples are lauryl alcohol, myristyl alcohol, cetyl alcohol, palmoleyl alcohol, stearyl alcohol, isostearyl alcohol, oleyl alcohol, elaidyl alcohol, petroselinyl alcohol, arachyl alcohol, gadoleyl alcohol, behenyl alcohol, erucyl alcohol, brassidyl alcohol, and technical mixtures thereof which can be obtained as described above.
  • Preference is given to alkyl oligoglucosides based on hydrogenated C 12/14 coconut alcohol having a DP of 1 to 3.
  • alkylene oxide addition products of saturated linear fatty alcohols and fatty acids with in each case 2 to 100 mol of ethylene oxide per mole of fatty alcohol or fatty acid have proven to be very particularly preferred nonionic surfactants. Preparations with excellent properties are also obtained when they contain as nonionic surfactants C 12 -C 30 fatty acid mono- and diesters of addition products of 1 to 30 moles of ethylene oxide with glycerol and / or addition products of 5 to 60 moles of ethylene oxide with castor oil and hydrogenated castor oil ,
  • both products with a "normal” homolog distribution and those with a narrow homolog distribution can be used.
  • "normal” homolog distribution are meant mixtures of homologs obtained in the reaction of fatty alcohol and alkylene oxide using alkali metals, alkali metal hydroxides or alkali metal alcoholates as catalysts. Narrowed homolog distributions are obtained when, for example, hydrotalcites, alkaline earth metal salts of ether carboxylic acids, alkaline earth metal oxides, hydroxides or alkoxides are used as catalysts. The use of products with narrow homolog distribution may be preferred.
  • the agents according to the invention as surfactant very particularly preferably contain at least one addition product of from 15 to 100 mol of ethylene oxide, in particular from 15 to 50 mol of ethylene oxide, to a linear or branched (in particular linear) fatty alcohol having from 8 to 22 carbon atoms.
  • ethylene oxide in particular from 15 to 50 mol of ethylene oxide
  • linear or branched (in particular linear) fatty alcohol having from 8 to 22 carbon atoms.
  • These are very particularly preferably Ceteareth-15, Ceteareth-25 or Ceteareth- 50, which are marketed as Eumulgin ® CS 15 (Cognis), Cremophor A25 (BASF SE) or Eumulgin ® CS 50 (Cognis).
  • Suitable anionic surfactants are in principle all anionic surfactants suitable for use on the human body. These are characterized by a water-solubilizing, anionic group such as. As a carboxylate, sulfate, sulfonate or phosphate group and a lipophilic alkyl group having about 8 to 30 carbon atoms. In addition, glycol or polyglycol ether groups, ester, ether and amide groups and hydroxyl groups may be present in the molecule.
  • cationic surfactants of the quaternary ammonium compound type are ammonium halides, in particular chlorides and bromides, such as alkyltrimethylammonium chlorides, dialkyldimethylammonium chlorides and trialkylmethylammonium chlorides.
  • the long alkyl chains of these surfactants preferably have 10 to 18 carbon atoms, such as.
  • cetyl trimethyl ammonium chloride stearyl trimethyl ammonium chloride, distearyl dimethyl ammonium chloride, lauryl dimethyl ammonium chloride, lauryl dimethyl benzyl ammonium chloride and tricetylmethyl ammonium chloride.
  • Further preferred cationic surfactants are the imidazolium compounds known under the INCI names Quaternium-27 and Quaternium-83.
  • Zwitterionic surfactants are surface-active compounds which contain at least one quaternary ammonium group and at least one -COO ⁇ _) in the molecule - or -S03 _ ⁇ ) - Wear group.
  • Particularly suitable zwitterionic surfactants are the so-called betaines such as N-alkyl-N, N-dimethylammonium glycinates, for example cocoalkyl dimethylammonium glycinate, N-acylaminopropyl N, N-dimethylammonium glycinates, for example cocoacylaminopropyldimethylammonium glycinate, and 2-alkyl-3-carboxymethyl-3-hydroxyethyl-imidazolines having in each case 8 to 18 C atoms in the alkyl or acyl group, and the cocoacylaminoethylhydroxyethylcarboxymethylglycinate.
  • a preferred zwitterionic surfactant is the fatty acid
  • Ampholytes are understood as meaning those surface-active compounds which, apart from a Cs-C24-alkyl or -acyl group in the molecule, contain at least one free amino group and at least one -COOH or -SCH group and are capable of forming internal salts.
  • Suitable ampholytes include N-alkylglycines, N-alkylpropionic acids, N-alkylaminobutyric acids, N-alkyliminodipropionic acids, N-hydroxyethyl-N-alkylamidopropylglycines, N-alkyltaurines, N-alkylsarcosines, 2-alkylaminopropionic acids and alkylaminoacetic acids each having about 8 to 24 C - atoms in the alkyl group.
  • Particularly preferred ampholytes are N-cocoalkylaminopropionate, cocoacylaminoethylaminopropionate and C12-C18 acylsarcosine.
  • compositions of the invention may further contain the auxiliaries and additives which are usually added to conventional styling agents.
  • auxiliaries and additives in particular additional care substances are mentioned.
  • the agent may contain, for example, at least one protein hydrolyzate and / or one of its derivatives.
  • Protein hydrolysates are product mixtures obtained by acid, alkaline or enzymatically catalyzed degradation of proteins (proteins).
  • the term protein hydrolyzates also means total hydrolyzates as well as individual amino acids and their derivatives as well as mixtures of different amino acids.
  • polymers made up of amino acids and amino acid derivatives are understood by the term protein hydrolyzates. The latter include, for example, polyalanine, polyasparagine, polyserine, etc.
  • Further examples of compounds which can be used according to the invention are L-alanyl-L-proline, polyglycine, glycyl-L-glutamine or D / L-methionine-S-methylsulfonium chloride.
  • ⁇ -amino acids and their derivatives such as ⁇ -alanine, anthranilic acid or hippuric acid can also be used.
  • the molecular weight of the protein hydrolysates which can be used according to the invention is between 75, the molecular weight for glycine, and 200,000, preferably the molecular weight is 75 to 50,000 and very particularly preferably 75 to 20,000 daltons.
  • protein hydrolysates of both vegetable and animal or marine or synthetic origin can be used.
  • Animal protein hydrolysates are, for example, elastin, collagen, keratin, silk and milk protein hydrolysates, which may also be present in the form of salts.
  • Such products are, for example, under the trademarks Dehylan ® (Cognis), Promois® ® (Interorgana) Collapuron ® (Cognis), Nutrilan® ® (Cognis), Gelita-Sol ® (German Gelatinefabriken Stoess & Co), Lexein ® (Inolex) sericin (Pentapharm) and kerasol tm ® (Croda) sold.
  • Protein hydrolysates of vegetable origin eg. As soybean, almond, pea, potato and wheat protein hydrolysates are, for example, under the trademarks Gluadin ® (Cognis), DiaMin ® (Diamalt), Lexein ® (Inolex), Hydrosoy ® (Croda), Hydrolupin ® (Croda) , hydro Sesame ® (Croda), Hydro tritium ® (Croda) and Crotein ® (Croda) available.
  • the use of the protein hydrolysates is preferred as such, amino acid mixtures obtained otherwise may optionally be used instead.
  • derivatives of protein hydrolysates for example in the form of their fatty acid condensation products. Such products are marketed for example under the names Lamepon ® (Cognis), Lexein ® (Inolex), Crolastin ® (Croda), Crosilk ® (Croda) or Crotein ® (Croda).
  • the protein hydrolysates may be present in the agents according to the invention, for example in concentrations of from 0.01% by weight to 20% by weight, preferably from 0.05% by weight up to 15% by weight and most preferably in amounts of from 0 , 05 wt .-% up to 5 wt .-%, in each case based on the total application preparation.
  • the agent according to the invention may further comprise at least one vitamin, a provitamin, a vitamin precursor and / or one of their derivatives.
  • vitamins, provitamins and vitamin precursors are preferred, which are usually assigned to groups A, B, C, E, F and H.
  • the group of substances designated as vitamin A includes retinol (vitamin A and 3,4-didehydroretinol (vitamin A 2 ) .beta.-carotene is the provitamin of retinol.)
  • the vitamin A component is, for example, vitamin A acid and their esters, vitamin A aldehyde and vitamin A alcohol, as well as its esters, such as the palmitate and the acetate,
  • the compositions preferably contain the vitamin A component in amounts of 0.05-1% by weight, based on the entire application preparation.
  • the vitamin B group or the vitamin B complex include u. a.
  • Vitamin B 1 (thiamine)
  • Vitamin B 2 (riboflavin)
  • Vitamin B 3 Under this name, the compounds nicotinic acid and nicotinamide (niacinamide) are often performed. Preferred according to the invention is the nicotinic acid amide, which is preferably contained in the agents according to the invention in amounts of from 0.05 to 1% by weight, based on the total application preparation. Vitamin B 5 (pantothenic acid, panthenol and pantolactone). Panthenol and / or pantolactone are preferably used in the context of this group. Derivatives of panthenol which can be used according to the invention are, in particular, the esters and ethers of panthenol and also cationically derivatized panthenols.
  • panthenol triacetate panthenol monoethyl ether and its monoacetate, as well as cationic panthenol derivatives.
  • the said compounds of the vitamin B 5 type are preferably present in the agents according to the invention in amounts of 0.05-10% by weight, based on the total application preparation. Amounts of 0, 1-5 wt .-% are particularly preferred.
  • Vitamin B 6 (pyridoxine and pyridoxamine and pyridoxal).
  • the compounds of the vitamin B 6 type mentioned are preferably contained in the agents according to the invention in amounts of 0.01-5% by weight, based on the total application preparation. Levels of 0.05-1 wt% are particularly preferred.
  • Vitamin C (ascorbic acid). Vitamin C is used in the inventive compositions preferably in amounts of 0.1 to 3 wt .-%, based on the total application preparation. Use in the form of palmitic acid ester, glucosides or phosphates may be preferred. The use in combination with tocopherols may also be preferred.
  • Vitamin E tocopherols, especially ⁇ -tocopherol.
  • Tocopherol and its derivatives which include in particular the esters such as acetate, nicotinate, phosphate and succinate, are preferably present in the compositions according to the invention in amounts of 0.05-1% by weight, based on the total application preparation.
  • Vitamin F is usually understood as meaning essential fatty acids, in particular linoleic acid, linolenic acid and arachidonic acid.
  • Vitamin H is the compound (3aS, 4S, 6aR) -2-oxohexahydrothienol [3,4-cf] - imidazole-4-valeric acid, for which, however, the trivial name biotin has meanwhile prevailed.
  • Biotin is contained in the agents according to the invention preferably in amounts of 0.0001 to 1, 0 wt .-%, in particular in amounts of 0.001 to 0.01 wt .-%, each based on the total application preparation.
  • the agents according to the invention preferably contain vitamins, provitamins and vitamin precursors from groups A, B, C, E and H. Panthenol, pantolactone, pyridoxine and its derivatives as well as nicotinamide and biotin are particularly preferred.
  • the addition of panthenol increases the flexibility of the polymer film formed using the composition of the present invention.
  • the compositions according to the invention may contain panthenol instead of or in addition to glycerol and / or propylene glycol.
  • the agents according to the invention contain panthenol, preferably in an amount of 0.05 to 10% by weight, particularly preferably 0.1 to 5% by weight, in each case based on the total agent.
  • compositions according to the invention may further comprise at least one extra kt plant.
  • extracts are produced by extraction of the whole plant. However, in individual cases it may also be preferred to prepare the extracts exclusively from flowers and / or leaves of the plant.
  • extracts of green tea, almond, aloe vera, coconut, mango, apricot, lime, wheat, kiwi and melon are especially suitable.
  • the plant extracts can be used according to the invention both in pure and in diluted form. If they are used in diluted form, they usually contain about 2 to 80 wt .-% of active substance and as a solvent used in their extraction agent or extractant mixture.
  • compositions according to the invention mixtures of several, especially two, different plant extracts.
  • compositions of the invention contain these care substances preferably in amounts of 0.001 to 2, in particular from 0.01 to 0.5 wt .-%, each based on the total application preparation.
  • a UV filter By adding a UV filter, both the agents themselves and the treated fibers can be protected from the harmful effects of UV radiation.
  • at least one UV filter is added to the agent.
  • the suitable UV filters are not subject to any general restrictions with regard to their structure and their physical properties. On the contrary, all UV filters which can be used in the cosmetics sector and whose absorption maximum lies in the UVA (315-400 nm), in the UVB (280-315 nm) or in the UVC ( ⁇ 280 nm) range are suitable. UV filters with an absorption maximum in the UVB range, in particular in the range from about 280 to about 300 nm, are particularly preferred.
  • the UV filters preferred according to the invention can be selected, for example, from substituted benzophenones, p-aminobenzoic acid esters, diphenylacrylic acid esters, cinnamic acid esters, salicylic acid esters, benzimidazoles and o-aminobenzoic acid esters.
  • UV filters which can be used according to the invention are 4-aminobenzoic acid, ⁇ , ⁇ , ⁇ -trimethyl-4- (2-oxoborn-3-ylidenemethyl) aniline methylsulfate, 3,3,5-trimethylcyclohexyl salicylate (homosalates), 2-hydroxy-4-methoxy-benzophenone (benzophenone-3; Uvinul ® M 40, Uvasorb MET ®, ® Neo Heliopan BB, Eusolex ® 4360), 2-phenylbenzimidazole-5-sulfonic acid and potassium, sodium and triethanolamine salts ( Phenylbenzimidazole Sulfonic Acid; Parsol ® HS; Neo Heliopan Hydro ®), 3,3 '- (1, 4-phenylenedimethylene) bis (7,7-dimethyl-2-oxo-bicyclo [2.2.1] hept-1- yl methane-sulfonic acid) and salts thereof, 1- (4-tert-buty
  • the UV filters are usually contained in amounts of 0.01-5 wt .-%, based on the total application preparation. Amounts of 0, 1-2.5 wt .-% are preferred.
  • Thickeners such as agar-agar, guar gum, alginates, xanthan gum, gum arabic, karaya gum, locust bean gum, linseed gums, dextrans, cellulose derivatives, e.g. For example, methylcellulose, hydroxyalkylcellulose and carboxymethylcellulose, starch fractions and derivatives such as amylose, amylopectin and dextrins, clays such. Bentonite, fully synthetic hydrocolloids such as e.g. Polyvinyl alcohol, and optionally crosslinked polyacrylates,
  • Structurants such as maleic acid and lactic acid
  • Anti-dandruff agents such as Piroctone Olamine, Zinc Omadine and Climbazole,
  • Bodying agents such as sugar esters, polyol esters or polyol alkyl ethers,
  • Swelling and penetration substances such as glycerol, propylene glycol monoethyl ether, carbonates,
  • Opacifiers such as latex, styrene / PVP and styrene / acrylamide copolymers
  • Pearlescing agents such as ethylene glycol mono- and distearate and PEG-3-distearate,
  • composition of the invention is for use on the keratin-containing fibers of a first composition comprising in a cosmetic carrier at least one macromolecule having at least one alkoxysilyl functionality of the formula
  • Alkyl group (in particular methyl or ethyl), x is 1, 2 or 3,
  • R is -O-Si-K'-R 2
  • R 1 is a (C 1 to C 4 ) -alkyl group
  • K ' represents a connectivity selected from a covalent bond or from a molecular fragment having two free valences
  • R 2 is a structural fragment comprising at least one substituent selected from quaternary ammonium group, tertiary amino group, secondary amino group, primary amino group, anionic group
  • the first composition contains as cosmetic carrier preferably an alcoholic cosmetic carrier. Possible but less preferred are aqueous alcoholic carriers. If water is contained in the first composition, its amount should be kept as small as possible.
  • the first composition preferably contains less than 1.5% by weight of free water.
  • alcohols it is possible in particular to use the lower alcohols having 1 to 4 carbon atoms usually used for cosmetic purposes, such as, for example, ethanol and isopropanol.
  • the first composition additionally contains at least one alcohol having 2 to 6 carbon atoms and 1 to 3 hydroxyl groups.
  • This additional alcohol is again preferably selected from at least one compound of the group formed from ethanol, ethylene glycol, isopropanol, 1,2-propylene glycol, 1,3-propylene glycol, glycerol, n-butanol, 1,3-butylene glycol.
  • a most preferred alcohol is ethanol.
  • the additional alcohol having 2 to 6 carbon atoms and 1 to 3 hydroxyl groups is preferably in the composition of the present invention in an amount of 20% by weight to 65% by weight, especially 25% by weight to 50% by weight, respectively based on the entire first composition.
  • organic solvents or a mixture of solvents having a boiling point below 400 ° C in an amount of 0, 1 to 15 weight percent, preferably from 1 to 10 weight percent based on the total agent may be included.
  • Particularly suitable as additional co-solvents are unbranched or branched hydrocarbons such as pentane, hexane, isopentane and cyclic hydrocarbons such as cyclopentane and cyclohexane.
  • particularly preferred water-soluble solvents is polyethylene glycol in an amount of up to 30 wt .-% based on the entire first composition.
  • a second article of the invention is a kit-of-parts comprising
  • composition comprising, in a cosmetic carrier, at least one macromolecule having at least one alkoxysilyl functionality of the formula (RO) n R ' (3 - n) Si- * , in which R and R' independently of one another are C 1 to C 4 ) -alkyl group (in particular methyl or ethyl), x is 1, 2 or 3,
  • composition comprising, in a cosmetic carrier, at least one trialkoxysilane of the formula (T-1)
  • R is -O-Si-K'-R 2
  • R 1 is a (C 1 to C 4 ) -alkyl group
  • K ' represents a connectivity selected from a covalent bond or from a molecular fragment having two free valences
  • R 2 is a structural fragment comprising at least one substituent selected from quaternary ammonium group, tertiary amino group, secondary amino group, primary amino group, anionic group
  • the two compositions are spatially separated from each other in a separate container.
  • the respective containers may be, for example, bottles or cans, for example made of materials such as plastic, metal or glass.
  • a container according to the invention may also be a chamber of a multi-chamber container. This multi-chamber container may comprise a device which makes it possible to remove both compositions simultaneously from the multi-chamber container. In this case, the compositions can be mixed automatically before or after leaving the multi-chamber container.
  • a third subject of the invention is a process for the permanent transformation of keratin-containing fibers, in particular human hair, in which
  • the fibers are optionally rinsed and dried after a contact time.
  • Winding aids such as Curlers or papillots in the case of a perm, or aids for a mechanical smoothing, such as a comb or a brush, a
  • deformation aids such as winding aids
  • the reaction time is preferably 5 to 20 minutes, more preferably 10 to 15 minutes.
  • the keratin-containing fibers are moistened prior to step (i). This can be done by spraying the fibers with a liquid, such as water.
  • a liquid such as water.
  • the fibers are shampooed with a conventional shampoo, rinsed and then toweled with a towel. After completion of the terry step remains a noticeable residual moisture in the hair back. It is also according to the invention for moistening a means of the first or the second container (see kit of parts of the second subject of the invention) to bring into contact with the hair.
  • the agent of the kit-of-parts according to the invention is applied to the fibers which has not previously been used for moistening.
  • the agent according to the invention of the first subject of the invention is formed on the keratin-containing fibers.
  • steps (ii) and (iii) are those mentioned in the first subject of the invention (vide supra).
  • the hair before step (ii) is subjected to a heat treatment, in particular at temperatures of 80 ° C. to 250 ° C., more preferably at temperatures of 120 ° C. to 200 ° C.
  • a heat source acts preferably a - in particular at 80 ° C to 250 ° C, more preferably at 120 ° C to 200 ° C - heated solid is brought into direct contact with the hair. This is the case in particular when using corrugated iron or flat iron.
  • the fibers in step (iii) are subjected to a heat treatment with mechanical smoothing of the fiber at a temperature of 120-220 ° C.
  • a strand of hair is wound around a suitably tempered, rounded body, for example a rod-shaped or tubular body, and unwound again after a residence time of 10 to 30 seconds.
  • a mechanical smoothing is understood according to the invention to mean stretching of the curly hair along the longest spatial extent of the hair fiber.
  • the heat treatment with mechanical smoothing of the hair preferably takes place at a temperature of 140-200 ° C.
  • the heat treatment can be done with hot air. In this case, the hair is heated during the combing exactly at the point where the mechanical smoothing takes place.
  • the heat treatment in the manner of smoothing by means of appropriately tempered plates, in particular metal or ceramic plates, takes place, in which the plate is pressed onto the hair to be smoothed and moved to the hair pressed plate along the hair fiber becomes.
  • the plates may optionally be coated with heat resistant materials.
  • the hair fiber to be smoothed is pressed between two appropriately tempered plates and both plates are simultaneously moved along the longest spatial extent of the fiber. It is again preferred that both plates are connected to each other, so that both plates can be moved uniformly along the hair fiber. If the heat treatment is performed on the living hair, the hair fiber is attached to one end (hair root). The plates are in this case preferably moved evenly away from the hair root along the entire hair fiber.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)

Abstract

L'invention concerne des produits pour traiter des fibres kératiniques, en particulier les cheveux, ces produits contenant dans un support cosmétiquement acceptable (i) au moins une macromolécule portant au moins une fonctionnalité alcoxysilyle de formule (RO)nR'(3-n)Si-*, dans laquelle R et R' représentent indépendamment un groupe (C1-C4)alkyle (en particulier méthyle ou éthyle) et x est égal à 1, 2 ou 3, et (ii) au moins un trialcoxysilane de formule (T-1), dans laquelle R1 représente un groupe (C1-C4)alkyle, K' représente une connectivité choisie parmi une liaison covalente ou un fragment de molécule à deux valences libres, R2 représente un fragment de structure comprenant au moins un substituant choisi parmi un groupe ammonium quaternaire, un groupe amino tertiaire, un groupe amino secondaire, un groupe amino primaire et un groupe anionique. Ces produits permettent d'obtenir une bonne résistance au lavage pour les coiffures fixées au moyen desdits produits.
EP10785091A 2009-12-30 2010-12-08 Produit de traitement des cheveux comprenant des composés substitués par des trialcoxysilanes et des macromolécules modifiées par des alcoxysilyles Withdrawn EP2519219A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102009055404A DE102009055404A1 (de) 2009-12-30 2009-12-30 Haarbehandlungsmittel umfassend Trialkoxysilan-substituierte Verbindungen und Alkoxysilyl-modifizierte Makromoleküle
PCT/EP2010/069148 WO2011080034A2 (fr) 2009-12-30 2010-12-08 Produit de traitement des cheveux comprenant des composés substitués par des trialcoxysilanes et des macromolécules modifiées par des alcoxysilyles

Publications (1)

Publication Number Publication Date
EP2519219A2 true EP2519219A2 (fr) 2012-11-07

Family

ID=44169988

Family Applications (1)

Application Number Title Priority Date Filing Date
EP10785091A Withdrawn EP2519219A2 (fr) 2009-12-30 2010-12-08 Produit de traitement des cheveux comprenant des composés substitués par des trialcoxysilanes et des macromolécules modifiées par des alcoxysilyles

Country Status (4)

Country Link
US (1) US20120260934A1 (fr)
EP (1) EP2519219A2 (fr)
DE (1) DE102009055404A1 (fr)
WO (1) WO2011080034A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102011089063A1 (de) * 2011-12-19 2013-06-20 Henkel Ag & Co. Kgaa Zusammensetzungen zur Färbung keratinhaltiger Fasern
WO2013087319A2 (fr) * 2011-12-13 2013-06-20 Henkel Ag & Co. Kgaa Compositions pour la coloration de fibres keratiniques
DE102011089040A1 (de) * 2011-12-19 2013-06-20 Henkel Ag & Co. Kgaa Kosmetikum mit alkoxysilylfunktionalisierten, wasserlöslichen Polymeren und speziellen polaren Alkoxysilanen
FR2985905B1 (fr) 2012-01-23 2014-10-17 Oreal Composition comprenant au moins un polymere alcoxysilane particulier
DE102013216787A1 (de) 2013-08-23 2015-02-26 Evonik Degussa Gmbh Guanidingruppen aufweisende semi-organische Siliciumgruppen enthaltende Verbindungen
FR3030240B1 (fr) * 2014-12-23 2017-07-28 Oreal Procede de traitement des fibres keratiniques avec une composition comprenant un acide amine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19738866A1 (de) 1997-09-05 1999-03-11 Henkel Kgaa Schaumarme Tensidmischungen mit Hydroxymischethern
JP3905437B2 (ja) * 2002-07-22 2007-04-18 株式会社資生堂 毛髪処理剤
FR2891143B1 (fr) * 2005-09-23 2007-11-16 Oreal Composition cosmetique comprenant un compose organique du silicium, et procede de mise en forme des cheveux
FR2910311B1 (fr) * 2006-12-20 2009-02-13 Oreal Composition comprenant un compose silicone et un organosilane particulier
DE102007039665A1 (de) * 2007-08-22 2009-02-26 Sustech Gmbh & Co. Kg Silylfunktionelle lineare Präpolymere, deren Herstellung und Verwendung

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2011080034A2 *

Also Published As

Publication number Publication date
WO2011080034A3 (fr) 2012-08-23
WO2011080034A2 (fr) 2011-07-07
DE102009055404A1 (de) 2011-07-07
US20120260934A1 (en) 2012-10-18

Similar Documents

Publication Publication Date Title
EP1656184B1 (fr) Procede pour lisser des fibres keratiniques
EP1812117B1 (fr) Procede de restructuration de fibres keratiniques
EP2020227B1 (fr) Dérivés de cellulose cationiques en cosmétique
EP2111852A2 (fr) Procédé de traitement pour le soin des cheveux
EP2519219A2 (fr) Produit de traitement des cheveux comprenant des composés substitués par des trialcoxysilanes et des macromolécules modifiées par des alcoxysilyles
EP1179339B1 (fr) Produit cosmétique contenant des extraits de graines de "malvaceae"
WO2005115315A1 (fr) Procede et composition pour restructurer des fibres de keratine
EP1404286B1 (fr) Agent de soin capillaire comprenant un tartrate de carnitine
EP1779845B1 (fr) Utilisation de dérivés de cellulose cationiques en cosmétique
EP2519216B1 (fr) Agent de traitement capillaire comprenant un trialcoxysilane spécial et un adjuvant supplémentaire
DE19540853A1 (de) Haarbehandlungsmittel
EP1786520B1 (fr) Composition et procede pour lisser des fibres keratiniques
EP0662815B1 (fr) Agent de soins capillaires
EP2506823A1 (fr) Utilisation d'huile-ester dans un procédé de mise en forme permanente des cheveux
EP1302191B1 (fr) Composition moussante pour le soin de la chevelure
EP1830798B1 (fr) Agents de traitement capillaire contenant des proteines ou polypeptides de corneocyte et des silicones
DE102011089578A1 (de) Umformungsmittel für keratinhaltige Fasern vermittelt starken Halt und natürliche Erscheinung
WO2008031685A1 (fr) Extrait de racine issu de harpagophytum pour stimuler la pousse des cheveux
DE10258394A1 (de) Tücher zur Pflege keratinischer Fasern
DE4317576A1 (de) Haarnachbehandlungsmittel
DE4232512A1 (de) Haarbehandlungsmittel
EP1569605B1 (fr) Etoffes de nettoyage pour nettoyer des fibres de keratine
WO2008031684A1 (fr) Extrait de apium graveolens pour stimuler la pousse des cheveux
EP1637123A1 (fr) Préparation pour la libération enzymatique in situ d'un agent de soin pour les fibres keratiniques
EP1830797A1 (fr) Agents de traitement capillaire contenant des proteines ou polypeptides de corneocyte

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20120619

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20140701